PANX1 overexpression has been associated with a worse prognosis in breast and liver cancer patients, which mechanistically is linked to PANX1-dependent enhancement of epithelial–mesenchymal transition and thus cell invasion [41,42]. The gene discussed is PANX1; the disease is liver cancer.